Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team

GlobeNewswire14:00

Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team (ELT) with immediate effect. “We have entered the final year of...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481543218?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vtOyV58KsIYMzqeBgs6Kag--~B/aD0xMTgyO3c9MjQ3MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/133f9853fa5e77f27e2587159807b598","is_english":true,"pubTime":"2024-11-05 14:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481543218","market":"us","top_or_hot":-1,"title":"Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team","media":"GlobeNewswire","content":"<div>\n<p>Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team (ELT) with immediate effect.\n“We have entered the final year of...</p>\n\n<a href=\"https://finance.yahoo.com/news/coloplast-announcement-no-05-2024-060000812.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColoplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-05 14:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/coloplast-announcement-no-05-2024-060000812.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team (ELT) with immediate effect.\n“We have entered the final year of...</p>\n\n<a href=\"https://finance.yahoo.com/news/coloplast-announcement-no-05-2024-060000812.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4161","symbol_name":"工业机械","start_time":0,"source_url":"https://finance.yahoo.com/news/coloplast-announcement-no-05-2024-060000812.html","article_id":"2481543218","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vtOyV58KsIYMzqeBgs6Kag--~B/aD0xMTgyO3c9MjQ3MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/133f9853fa5e77f27e2587159807b598"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481543218","pubTimestamp":1730786400,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team  with immediate effect.Building an Advanced Wound Care business for the future“We have also invested to become a bigger player in Advanced Wound Care in both dressings and biologics. With our dressings business, our strategic priority is to strengthen our commercial focus and significantly improve profitability. With Kerecis, we are focused on delivering year two of our commercial plan and transitioning the business onto Coloplast’s IT infrastructure as the next step in building a biologics category leader. Our Advanced Wound Care business will be represented in the ELT once we have successfully concluded the Kerecis integration and have delivered on the profit improvement plans for the dressings business,” says Kristian Villumsen.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4161":"工业机械","BK4120":"环境与设施服务","TISI":"Team Inc","CVR":"芝加哥机械","CLPBY":"Coloplast AS","CLPBF":"Coloplast AS","BK4198":"医疗保健用品"},"translate_title":"康乐保A/S-公告编号05/2024-康乐保扩大执行领导团队","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVR":1,"TISI":1,"CLPBF":0.9,"CLPBY":0.9},"content_text":"Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team (ELT) with immediate effect.\n“We have entered the final year of our 2025 strategy. In this strategic period, Coloplast has made significant investments to expand the reach of the company and build four growth platforms, Chronic Care, Voice & Respiratory Care, Advanced Wound Care and Interventional Urology, which must drive value creation in the years to come. We are expanding the ELT to reflect this,” says Kristian Villumsen, Coloplast CEO.\nOne Chronic Care organisationIn the new ELT, the Chronic Care business, which includes the Innovation unit and the commercial organisation, will be gathered under one senior leader: Nicolai Buhl, Executive Vice President, Chronic Care. \n“In our current strategic period, we have strengthened our innovation focus and brought more products to market. We have also invested in our commercial organisation across the US, Europe and Emerging Markets to continue to take market share. The next strategic period will be very much about realizing the potential of these investments and our new innovations, and it will require singular responsibility for the Chronic Care business. Executive Vice President Paul Marcun is retiring after two successful periods in Coloplast and 36 years in MedTech, and I want to thank Paul for his contribution to the company,” says Kristian Villumsen.\nIncluding Voice & Respiratory Care and Interventional Urology in the ELTThe new ELT will include two new members, Caroline Vagner Rosenstand, Executive Vice President, Voice & Respiratory Care, and Thomas Johns Jr., Executive Vice President, Interventional Urology.\n“Caroline and Tommy are both experienced and respected Coloplast leaders. Caroline has been leading Atos Medical, Voice & Respiratory Care, since our acquisition of the company, and she has built a strong team around her and delivered high growth rates consistently. Tommy has been leading Interventional Urology since January 2023, charting a course for future growth acceleration through both organic and inorganic investments into innovation and the commercial organisation.” says Kristian Villumsen.\nBuilding an Advanced Wound Care business for the future“We have also invested to become a bigger player in Advanced Wound Care in both dressings and biologics. With our dressings business, our strategic priority is to strengthen our commercial focus and significantly improve profitability. With Kerecis, we are focused on delivering year two of our commercial plan and transitioning the business onto Coloplast’s IT infrastructure as the next step in building a biologics category leader. Our Advanced Wound Care business will be represented in the ELT once we have successfully concluded the Kerecis integration and have delivered on the profit improvement plans for the dressings business,” says Kristian Villumsen.\nThe new Coloplast ELT1     \n\nKristian Villumsen, President and CEO\nAnders Lonning-Skovgaard, Executive Vice President and CFO\nDorthe Rønnau, Executive Vice President, People & Culture\nAllan Rasmussen, Executive Vice President, Global Operations\nNicolai Buhl, Executive Vice President, Chronic Care\nCaroline Vagner Rosenstand, Executive Vice President, Voice & Respiratory Care\nThomas Johns Jr, Executive Vice President, Interventional Urology\n\n1. Kristian Villumsen, President and CEO, and Anders Lonning-Skovgaard, Executive Vice President and CFO, constitute the management registered with the Danish Business Authority.\nFor further information, please contact\nInvestors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. +45 4911 1111\nAleksandra DimovskaVice President, Investor RelationsTel. +45 4911 1800 / +45 4911 2458Email: dkadim@coloplast.com\nPress and mediaPeter MønsterSr. Media Relations ManagerTel. +45 4911 2623Email: dkpete@coloplast.com\nAddressColoplast A/SHoltedam 1DK-3050 HumlebaekDenmarkCompany reg. (CVR) no. 69749917\nWebsitewww.coloplast.com\nThis announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.\nColoplast was founded on passion, ambition, and commitment. We were born from a nurse’s wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound and Skin Care, Interventional Urology and Voice and Respiratory Care.\nThe Coloplast logo is a registered trademark of Coloplast A/S. © 2024-11.\nAll rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.\n Attachment \n\n 05_2024_Coloplast_expands_Executive_Leadership_Team","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481543218"}